Name | Fumarate hydratase-IN-1 |
---|---|
Synonyms |
Ethyl (3S,3aR)-1-(4-biphenylylmethyl)-3-[2-(methylamino)-2-oxoethyl]-2-oxo-1,2,3,4,5,6-hexahydro-3aH-indole-3a-carboxylate
3aH-Indole-3a-carboxylic acid, 1-([1,1'-biphenyl]-4-ylmethyl)-1,2,3,4,5,6-hexahydro-3-[2-(methylamino)-2-oxoethyl]-2-oxo-, ethyl ester, (3S,3aR)- |
Description | Fumarate hydratase-IN-1, an enzyme of the TCA cycle. Inhibition of fumarate hydratase-IN-1 can contribute to tumorigenicity in some cells. The use of a photoaffinity labeling strategy identified fumarate hydratase as the principal pharmacological target.[1]In vitro: The activity of this enzyme was measured using a well-established assay that monitored the conversion of fumarate into L-malate and subsequent oxidation of L-malate to oxaloacetate by malate dehydrogenase. Initial controls established that neither the carboxylic acid 3 nor ester 2 inhibited malate dehydrogenase Using this two-enzyme protocol we found that carboxylic acid 3 inhibited fumarate hydratase in a dose-dependent fashion in vitro. Besides, inhibition of fumarate hydratase can contribute to tumorigenicity in some cells.[1] |
---|---|
Related Catalog | |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 693.0±55.0 °C at 760 mmHg |
Molecular Formula | C27H30N2O4 |
Molecular Weight | 446.538 |
Flash Point | 372.9±31.5 °C |
Exact Mass | 446.220551 |
LogP | 4.77 |
Vapour Pressure | 0.0±2.2 mmHg at 25°C |
Index of Refraction | 1.616 |
Storage condition | 2-8℃ |